Yazar "Polat, R" seçeneğine göre listele

Listeleniyor 1 - 3 / 3
  • Küçük Resim Yok
    Öğe
    Antioxidant enzyme activities and oxidative stress in affective disorders
    (Lippincott Williams & Wilkins, 2004) Ozcan, ME; Gulec, M; Ozerol, E; Polat, R; Akyol, O
    Recent data from several reports indicate that free radicals are involved in the biochemical mechanisms underlying neuropsychiatric disorders in human. The results of several reports suggest that lower antioxidant defences against lipid peroxidation exist in patients with depression and that there is a therapeutic benefit from antioxidant supplementation in unstable manic-depressive patients. We investigated the antioxidant enzyme status and the indices of oxidative stress and lipid peroxidation end products in erythrocytes from patients with affective disorder. For this purpose, we measured superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT) activities, as well as malondialdehyde (MDA) and nitric oxide (NO) levels in patients with affective disorders (n=30) in both pre- and post-treatment periods, and in a control group (n = 21). CAT activities were significantly decreased in both pre-, and post-treatment periods in patients compared to the control group. GSH-Px activity in the pre-treatment period in the patients was significantly lower than both post-treatment patient and control groups. MDA levels were increased in both pre-, and post-treatment patient groups compared to the control group. NO level was lower in the pre-treatment patient group than in the control group. There were statistically significant correlations between SOD and MDA, and SOD and NO in the pre-treatment patient and control groups. Because the overall study sample was small, and the post-treatment patient group was even smaller, it can tentatively be suggested that the antioxidant system is impaired during a mood episode in patients with affective disorders, normalizing at the end of the episode. (C) 2004 Lippincott Williams Wilkins.
  • Küçük Resim Yok
    Öğe
    Efficacy of lithium,valproate and carbarnazepine after an acute episode
    (Blackwell Publishing, 2004) Ozcan, ME; Polat, R; Genc, M; Unal, S
    [Abstract Not Available]
  • Küçük Resim Yok
    Öğe
    Weight gain and improvement with quetiapine in bipolar I disorder - A case report
    (Pergamon-Elsevier Science Ltd, 2004) Ozcan, ME; Kaya, B; Polat, R
    Observations made with quetiapine (QUET) in this case give clues for some aspects of its use for patients with bipolar disorder. Weight gain (11 kg; 16.6% increase in 21 weeks) and improvement in manic symptoms occurred after QUET add-on to lithium (Li). Patient's mood improved after QUET add-on without causing extrapyramidal symptoms (EPS), while QUET was discontinued due to weight gain. Shortterm QUET add-on to Li may help mood stabilization in bipolar I disorder. Weight changes must be observed carefully. (C) 2003 Elsevier Inc. All rights reserved.